Abstract
The pathology associated with mut methylmalonic acidaemia (MMA) is caused by systemic accumulation of methylmalonate. Therefore, removal of methylmalonate from the circulation of affected individuals by an engineered metabolic system is proposed as a potential treatment. The haematopoietic cell is a potential site for such a metabolic system because of its direct contact with the accumulated metabolite and the demonstrated safety and ease in utilizing this cell. In this study, we assessed the feasibility of developing a haematopoietic cell-based methylmalonate sink by analysing propionate/methylmalonate metabolism in a variety of haematopoietic cells. The results show that propionate metabolism and methylmalonyl-CoA mutase (MCM) activity are intact in primary T cells, EBV-B cells, and CD34+ haematopoietic stem cell-derived granulocytes, whereas they are defective in those from a mut MMA child. Moreover, normal T and EBV-B cells clear methylmalonate from the medium at a significant rate. Transduction of MCM-deficient T cells with a recombinant retrovirus encoding the human MCM cDNA results in correction of propionate metabolism. These results establish the basis for developing haematopoietic cell-based metabolic sink therapy for mut MMA by T lymphocyte/haematopoietic stem cell-directed gene transfer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ampola MG, Mahoney MJ, Nakamura E, Tanaka K (1975) Prenantal therapy of a patient with vitamin–B12–responsive methylmalonic acidemia. N Engl J Med 293: 313–317.
Andrews E, Jansen R, Crane AM, Cholin S, McDonnell D, Ledley FD (1993) Expression of recombinant human methylmalonyl CoA mutase in primary mut fibroblasts and Saccharomyces cerevisiae. Biochem Med Metab Biol 50: 135–144.
Bergman EN (1990) Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70: 567–590.
Blaese RM, Culver KW, Miller AD, et al (1995) T lymphocyte–directed gene therapy for ADA–SCID: initial trial results after 4 years. Science 270: 475–480.
Bordignon C, Notarangelo LD, Nobili N, et al (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA–immunodeficient patients. Science 270: 470–474.
Bosch A, McCray PJ, Chang S, et al (1996) Proliferation induced by keratinocyte growth factor enhances in vivo retroviral–mediated gene transfer to mouse hepatocytes. J. Clin Invest 98: 2683–2687.
Bowling WM, Kennedy SC, Cai S, et al (1996) Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver. Hum Gene Ther 7: 2113–2121.
Broxmeyer HE, Cooper S, Yoder M, Hangoc G (1992) Human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells. Curr Top Microbiol Immunol 177: 195–204.
Bunnell BA, Mesler Muul L, Donahye RE, Blaese RM, Morgan RA (1995) High–efficiency retroviral–mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 92: 7739–7743.
Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR, Wilson JM (1991) Longterm improvement of hypercholesterolemia after ex vivo gene therapy in LDLR–deficient rabbits. Science 254: 1802–1805.
Coulombe JT, Shih VE, Levy HL (1981) Massachusetts metabolic disorders screening program II. Pediatrics 67: 26–31.
Clark KR, Sferra TJ, Johnson PR (1997) Recombinant adeno–associated viral vectors mediate long–term transgene expression in muscle. Hum Gene Ther 8: 659–669.
Crane AM, Martin LS, Valle D, Ledley FD (1992) Phenotype of disease in three patients with identical mutations in methylmalonyl CoA mutase Hum Genet 89: 259–264.
Fenjves ES, Schwartz PM, Blaese RM, Taichman LB (1997) Keratinocyte gene therapy for adenosine deaminase deficiency: a model approach for inherited metabolic disorders. Hum Gene Ther 8: 911–917.
Fenton WA, Rosenberg LE (1995) Disorders of propionate and methylmalonate metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw–Hill, 1423–1449.
Grossman M, Rader DJ, Muller DWM, et al (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nature Medicine 1: 1148–1154.
Hanenberg H, Hashino K, Konishi H, Hock RA, Kato I, Williams DA (1997) Optimization of fibronectin–assisted retorvial gene transfer into human CD34+ hematopietic cells. Hum Gene Ther 8: 2193–2206.
Harding CO, Wilk K, Chang D, Messing A, Wolff JA (1998) Metabolic engineering as therapy for inborn errors of metabolism–development of mice with phenylalanine hydroxylase expression in muscle. Gene Ther 5: 677–683.
Herzog RW, Hagstrom JN, Kung S–H, et al (1997) Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adenoassociated virus. Proc Natl Acad Sci USA 94: 5804–5809.
Hsia YE, Scully KJ, Roxenberg LE (1969) Defective propionate carboxylation in ketotic hyperglycinaemia. Lancet 1: 757–758.
Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM (1997) Sustained expression of genes delivered into liver and muscle by lentiviral vectors. Nature Genet 17: 314–317.
Kay MA, Baley P, Rothenberg S, et al (1992) Expression of human α1–antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 89: 89–93.
Kikuchi M, Hanamizu H, Narisawa K, Tada K (1989) Assay of methylmalonyl CoA mutase with high–performance liquid chromatography. Clin Chim Acta 184: 307–314.
Kitten O, Cosset FL, Ferry N (1997) Highly efficient retrovirus–mediated gene transfer into rat hepatocytes in vivo. Hum Gene Ther 8: 1491–1494.
Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD (1997) Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adenoassociated virus vectors. Proc Natl Acad Sci USA 94: 1426–1431.
Kohn DB, Weinberg KI, Nolta JA, et al (1995) Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine 1: 1017–1023.
Kohn DB, Hershfield MS, Carbonaro D, et al (1998) T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA–deficient SCD neonates. Nature Medicine 4: 775–780.
Kosai KI, Finegold MJ, Thi–Huynh BT, et al (1998) Retrovirus–mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum Gene Ther 9: 1293–1302.
Kuga T, Sakamaki S, Matsunaga T, et al (1997) Fibronectin fragment–facilitated retroviral transfer of the glutathione–S–transferase π Gene into CD34+ cells to protect them against alkylating agents. Hum Gene Ther 8: 1901–1910.
Lam JS, Reeves ME, Cowherd R, Rosenberg SA, Hwu P (1996) Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum Gene Ther 7: 1415–1422.
Ledley FD (1992) Transplantation in genetic disease. Curr Opin Pediatr 4: 972–997.
Ledley FD, Rosenblatt DS (1997) Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations. Hum Mutat 9: 1–6.
Lieber A, Peeters MJTFDV, Meuse L, Fausto N, Perkins J, Kay MA (1995) Adenovirusmediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci USA 92: 6210–6214.
Lin CM, Tan Y, Lee YM, Chang CC, Hsiao KJ (1997) Expression of human phenylalanine hydroxylase in T lymphocytes of classical phenylketonuria children by retroviral–mediated gene transfer. J Inher Metab Dis 20: 742–754.
Mahoney MJ, Rosenberg LE, Lindblad B, Walenstrom J, Zetterstrom R (1975) Prenatal diagnosis of methylmalonic acidemia. Acta Paediatr Scand 64: 44–48.
Matsui SM, Mahoney MJ, Rosenberg LE (1983) The natural history of the inherited methylmalonic acidemias. N Engl J Med 308: 857–861.
Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980–988.
Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242.
Miyake K, Suzuki N, Matsuoka H, Tohyama T, Shimada T (1998) Stable integration of human immunodeficiency virus–based retroviral vectors into the chromosomes of nondividing cells. Hum Gene Ther 9: 467–475.
Rosenberg SA, Aebersold P, Cornetta K, et al (1990) Gene transfer into humanÈ immunotherapy of patients with advanced melanoma, using tumor–infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570–578.
Rother RP, Squinto SP, Mason JM, Rollins SA (1995) Protection of retroviral vector particles in human blood through complement inhibition. Hum Gene Ther 6: 429–435.
Rund D, Dagan M, Dalyot–Herman N, et al (1998) Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions. Hum Gene Ther 9: 649–657.
Sawada T, Ledley FD (1992) Correction of methylmalonyl CoA mutase deficiency in mut0 fibroblasts and constitution of gene expression in primary human hepatocytes by retroviral–mediated gene transfer. Somatic Cell Mol Genet 18: 507–516.
Schuening F (1997) Clinical protocol: retrovirus–mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with gaucher's disease. Hum Gene Ther 8: 2143–2160.
Shevell MI, Matiaszuk N, Ledley FD, Rosenblatt DS (1993) Varying neurological phenotypes among mut0 and mut– patients with methylmalonyl CoA mutase deficiency. Am J Med Genet 45: 619–624.
Stankovics J, Crane AM, Andrews E, Wu CH, Wu GY, Ledley FD (1994) Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. Hum Gene Ther 5: 1095–1104.
Sullivan DM, Jensen Tg, Taichman LB, Csaky KG (1997) Ornithine–δ–aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy. Gene Ther 4: 1036–1044.
Synder RO, Miao CH, Patijn GA, et al (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genetics 16: 270–276.
Tanaka K, West–Pull A, Hine DG, Lynn TB, Lowe T (1980) Gas chromatographic method of analysis for urinary organic acid II: description of the procedure and its application in diagnosis of patients with organic acidurias. Clin Chem 26: 1847–1853.
Wilkemeyer M, Stankovics J, Foy T. Ledley FD (1992) Propionate metabolism in cultured human cells after overexpression of recombinant methylmalonyl CoA mutase: implication for somatic gene therapy. Somat Cell Mol Genet 18: 493–505.
Willard HF, Rosenberg LE (1979) Inborn errors of cobalamin metabolism: effect of cobalamin supplementation in culture on methylmalonyl CoA mutase activity in normal and mutant fibroblasts. Biochem Genet 17: 57–75.
Yang Y, Jooss KU, Su Q, Ertl HCJ, Wilson JM (1996) Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus–infected hepatocytes in vivo. Gene Ther 3: 137–144.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chang, CC., Hsiao, KJ., Lee, YM. et al. Towards metabolic sink therapy for mut methylmalonic acidaemia: Correction of methylmalonyl-CoA mutase deficiency in T lymphocytes from a mut methylmalonic acidaemia child by retroviral-mediated gene transfer. J Inherit Metab Dis 22, 773–787 (1999). https://doi.org/10.1023/A:1005593605399
Issue Date:
DOI: https://doi.org/10.1023/A:1005593605399